Sophiris Bio, Inc.
SPHS
SPHS was delisted on the 11th of March, 2020.
27 hedge funds and large institutions have $1.24M invested in Sophiris Bio, Inc. in 2019 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 5 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 2
40% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 5
8% more funds holding
Funds holding: 25 → 27 (+2)
65% less capital invested
Capital invested by funds: $3.56M → $1.24M (-$2.32M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wells Fargo
San Francisco,
California
|
+$238K |
| 2 |
Renaissance Technologies
New York
|
+$103K |
| 3 |
WS
Wedbush Securities
Los Angeles,
California
|
+$40.9K |
| 4 |
SM
Sabby Management
Miami Beach,
Florida
|
+$19.2K |
| 5 |
PAG
Private Advisor Group
Morristown,
New Jersey
|
+$9.08K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
-$2.21M |
| 2 |
BO
BRR OpCo
Columbus,
Ohio
|
-$23K |
| 3 |
Victory Capital Management
San Antonio,
Texas
|
-$3K |
| 4 |
VF
Virtu Financial
New York
|
-$1.03K |
| 5 |
Barclays
London,
United Kingdom
|
-$1K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
26
Victory Capital Management
San Antonio,
Texas
| – | -$3K | -5,073 | Closed |
|
|
27
Barclays
London,
United Kingdom
| – | -$1K | -1,353 | Closed |
|
SPHS Hedge Fund Activity: Q4 2019 in Review
27 of the 5,076 institutional investors tracked by Wall St. Rank reported a position in Sophiris Bio, Inc. (SPHS) for Q4 2019, worth a combined $1.24M — down 65% from $3.56M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new SPHS positions and 5 closed out — a net gain of 2 holders — while 4 added to existing stakes and 2 trimmed.
The largest buyer was Wells Fargo, opening a new position worth an estimated $238K. The largest seller was Armistice Capital, exiting entirely with an estimated $2.21M sold.
- 27 institutional investors held Sophiris Bio, Inc. (SPHS) as of Q4 2019, up from 25 in Q3 2019.
- Funds reported $1.24M of Sophiris Bio, Inc. stock for Q4 2019, down 65% quarter-over-quarter.
- 7 funds opened new Sophiris Bio, Inc. positions in Q4 2019 and 5 closed out, a net change of +2 holders.
- The largest Sophiris Bio, Inc. buyer in Q4 2019 was Wells Fargo, an estimated $238K added.
- The largest Sophiris Bio, Inc. seller in Q4 2019 was Armistice Capital, an estimated $2.21M sold.
Based on aggregated 13F filings for Q4 2019.